Cleared Special

K041093 - NUMED MULLINS X PTA CATHETER

K041093 is an FDA 510(k) clearance for NUMED MULLINS X PTA CATHETER, manufactured by NuMED, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Special 510(k) pathway after a 9-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2004
Decision
9d
Days
Class 2
Risk

K041093 is an FDA 510(k) clearance for the NUMED MULLINS X PTA CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by NuMED, Inc. (Hopkinton, US). The FDA issued a Cleared decision on May 6, 2004 after a review of 9 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all NuMED, Inc. devices

FDA 510(k) Submission Details - K041093

510(k) Number K041093 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 27, 2004
Decision Date May 06, 2004
Days to Decision 9 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
116d faster than avg
Panel avg: 125d · This submission: 9d
Pathway characteristics
Modification to existing cleared device.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 781
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K041093.
KERBEROS OCCLUDING GUIDE CATHETER AND ACCESSORIES
K041151 · Kerberos Proximal Solutions, Inc. · Jul 2004
CONCENTRIC RETRIEVER X5, MODEL 90035
K040700 · Concentric Medical, Inc. · Jun 2004
TRANSXCHANGE SUPPORT CATHETER
K033540 · Medtronic Vascular · May 2004
GORE TRI-LOBE BALLOON CATHETER
K033670 · W.L. Gore & Associates, Inc. · May 2004
ATB ALL-TERRAIN BALLOON PTA DILATATION CATHETER
K033875 · Cook, Inc. · Apr 2004
SAFE-CROSS DEFLECTING CATHETER, MODEL C118ND1
K040481 · Intra Luminal Therapeutics, Inc. · Mar 2004